Maha Katabi, Director, 10% Owner at Vera Therapeutics, Inc. (VERA), bought 266,666 shares at $15.00 ($4.0M) on 2022-02-10, disclosed to the SEC on 2022-02-14.
Open-market purchase of $4.0M VERA by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Negative factors outweigh the positive ones.
| Filing → |
| RYZB | BUY | 2023-09-21 | $4.2M | — | Filing → |
| AVTE | BUY | 2021-07-06 | $5.0M | — | Filing → |
| VERA | BUY | 2021-05-18 | $8.0M | — | Filing → |